Latest News about PFE
Recent news which mentions PFE
Pfizer Just Reassured Investors, but Is the Stock a Buy?
December 22, 2024
Tickers
PFE
From Motley Fool
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
December 22, 2024
From Motley Fool
The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025
December 21, 2024
From Motley Fool
My Top 10 Stocks to Buy for 2025
December 21, 2024
From Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
From Benzinga
Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?
December 19, 2024
Tickers
PFE
From Motley Fool
3 of the Safest Ultra-High-Yield Dividend Stocks to Buy in 2025
December 18, 2024
From Motley Fool
What's Going On With CVS Health, UnitedHealth And Cigna Group Shares?
December 17, 2024
From Benzinga
Stock Of The Day: Is Pfizer About To Break Out? Expect A New Uptrend If Resistance Breaks
December 17, 2024
Tickers
PFE
From Benzinga
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
December 17, 2024
From Benzinga
Pfizer Does Not Anticipate Material Changes To US Vaccine Policy From The Incoming Administration In 2025
December 17, 2024
From Benzinga
From Motley Fool
From Benzinga
Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030
December 16, 2024
From Motley Fool
Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children
December 13, 2024
From Benzinga
Bird Flu Spreads To Cats, Possibly Horses As Officials Signal No Plans To Authorize Vaccination
December 13, 2024
From Benzinga
From Benzinga
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
December 12, 2024
From Benzinga
Pfizer's Cancer Drug Ibrance Combo Therapy Extends Median Progression-Free Survival By Over 15 Months In certain Of Breast Cancer Patients
December 12, 2024
From Benzinga
Pfizer's Options: A Look at What the Big Money is Thinking
December 11, 2024
Tickers
PFE
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 11, 2024
From Benzinga
Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients
December 10, 2024
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Pfizer
December 10, 2024
Tickers
PFE
From Benzinga
3 Magnificent S&P 500 Dividend Stock Down 35% to Buy and Hold Forever
December 10, 2024
From Motley Fool
From Motley Fool
Want an Extra $1,000 of Dividend Income in 2025? Invest $11,400 in These 3 High-Yield Stocks.
December 07, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 05, 2024
From Benzinga
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
December 05, 2024
From Motley Fool
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
December 05, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.